{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:15:03Z","timestamp":1784556903565,"version":"3.55.0"},"reference-count":32,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Else Kr\u00f6ner-Fresenius Stiftung","award":["N\u00dc, 2014_A129"],"award-info":[{"award-number":["N\u00dc, 2014_A129"]}]},{"name":"Else Kr\u00f6ner-Fresenius Stiftung","award":["scholarship to HCA"],"award-info":[{"award-number":["scholarship to HCA"]}]},{"name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung","award":["N\u00dc, 2014_A129"],"award-info":[{"award-number":["N\u00dc, 2014_A129"]}]},{"name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung","award":["scholarship to HCA"],"award-info":[{"award-number":["scholarship to HCA"]}]},{"DOI":"10.13039\/501100003088","name":"Evangelisches Studienwerk Villigst","doi-asserted-by":"publisher","award":["N\u00dc, 2014_A129"],"award-info":[{"award-number":["N\u00dc, 2014_A129"]}],"id":[{"id":"10.13039\/501100003088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003088","name":"Evangelisches Studienwerk Villigst","doi-asserted-by":"publisher","award":["scholarship to HCA"],"award-info":[{"award-number":["scholarship to HCA"]}],"id":[{"id":"10.13039\/501100003088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Research and Management"],"published-print":{"date-parts":[[2022,9,22]]},"abstract":"<jats:p>There is no approved drug for fibromyalgia syndrome (FMS) in Europe. In the German S3 guideline, amitriptyline, duloxetine, and pregabalin are recommended for temporary use. The aim of this study was to cross-sectionally investigate the current practice of medication in FMS patients in Germany. We systematically interviewed 156 patients with FMS, while they were participating in a larger study. The patients had been stratified into subgroups with and without a decrease in intraepidermal nerve fiber density. The drugs most commonly used to treat FMS pain were nonsteroidal anti-inflammatory drugs (NSAIDs) (41.0% of all patients), metamizole (22.4%), and amitriptyline (12.8%). The most frequent analgesic treatment regimen was \u201con demand\u201d (53.9%), during pain attacks, while 35.1% of the drugs were administered daily and the remaining in other regimens. Median pain relief as self-rated by the patients on a numerical rating scale (0\u201310) was 2 points for NSAIDS, 2 for metamizole, and 1 for amitriptyline. Drugs that were discontinued due to lack of efficacy rather than side effects were acetaminophen, flupirtine, and selective serotonin reuptake inhibitors. Reduction in pain severity was best achieved by NSAIDs and metamizole. Our hypothesis that a decrease in intraepidermal nerve fiber density might represent a neuropathic subtype of FMS, which would be associated with better effectiveness of drugs targeting neuropathic pain, could not be confirmed in this cohort. Many FMS patients take \u201con-demand\u201d medication that is not in line with current guidelines. More randomized clinical trials are needed to assess drug effects in FMS subgroups.<\/jats:p>","DOI":"10.1155\/2022\/1217717","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T17:50:18Z","timestamp":1663869018000},"page":"1-8","source":"Crossref","is-referenced-by-count":18,"title":["Analgesic Medication in Fibromyalgia Patients: A Cross-Sectional Study"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1737-4458","authenticated-orcid":true,"given":"H.-C.","family":"Aster","sequence":"first","affiliation":[{"name":"Department of Neurology, University Hospital W\u00fcrzburg, W\u00fcrzburg 97080, Germany"},{"name":"Department of Child and Adolescent Psychiatry, Psychotherapy and Psychsomatics, University Hospital W\u00fcrzburg, W\u00fcrzburg 97080, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Evdokimov","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital W\u00fcrzburg, W\u00fcrzburg 97080, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Braun","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital W\u00fcrzburg, W\u00fcrzburg 97080, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6973-6428","authenticated-orcid":true,"given":"N.","family":"\u00dc\u00e7eyler","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital W\u00fcrzburg, W\u00fcrzburg 97080, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7064-5002","authenticated-orcid":true,"given":"C.","family":"Sommer","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital W\u00fcrzburg, W\u00fcrzburg 97080, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes279"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21931"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2019.1664510"},{"key":"4","article-title":"Pregabalin for pain in fibromyalgia in adults","volume":"9","author":"S. Derry","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3144-2"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq354"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1002\/art.20076"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-017-0207-0"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209724"},{"key":"10","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/485272","article-title":"Treatment of fibromyalgia syndrome: Recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies","volume":"2013","author":"J. Ablin","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"issue":"12","key":"11","article-title":"Guidelines for the diagnosis and treatment of the fibromyalgia syndrome","volume":"152","author":"J. N. Ablin","year":"2013","journal-title":"Harefuah"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines5020020"},{"issue":"5","key":"13","first-page":"717","article-title":"The role of tramadol in current treatment strategies for musculoskeletal pain","volume":"3","author":"S. A. Schug","year":"2007","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25565"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20140"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt053"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90154-4"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1177\/014662167700100306"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1037\/1040-3590.7.4.524"},{"key":"20","article-title":"Manual for the state-trait anxiety inventory","author":"C. Spielberger","year":"1983","journal-title":"Consulting Psychologists Press"},{"issue":"5","key":"21","first-page":"728","article-title":"The fibromyalgia impact questionnaire: development and validation","volume":"18","author":"C. S. Burckhardt","year":"1991","journal-title":"Journal of Rheumatology"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(01)01126-8"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2019.0537"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006681"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2011.00497.x"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22071"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-018-0689-1"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0665"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-014-1429-z"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1992.tb00541.x"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.7257\/1053-816x.2012.32.2.60"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012332.pub2"}],"container-title":["Pain Research and Management"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/prm\/2022\/1217717.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/prm\/2022\/1217717.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/prm\/2022\/1217717.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T17:50:32Z","timestamp":1663869032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/prm\/2022\/1217717\/"}},"subtitle":[],"editor":[{"given":"Marina","family":"De Tommaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":32,"alternative-id":["1217717","1217717"],"URL":"https:\/\/doi.org\/10.1155\/2022\/1217717","relation":{},"ISSN":["1918-1523","1203-6765"],"issn-type":[{"value":"1918-1523","type":"electronic"},{"value":"1203-6765","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,22]]}}}